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RESISTANCE to triclabendazole in field isolates of the liver
fluke Fasciola hepatica in sheep was described for the first time
by Overend and Bowen (1995) in Australia. In Europe, resis-
tance of F hepatica in sheep to triclabendazole has been
reported in Ireland (Lane 1998), Scotland (Mitchell and 
others 1998), Wales (Thomas and others 2000) and the
Netherlands (Moll and others 2000). On the Dutch farm
where resistance was found, the resistant flukes were present
in sheep and cattle.
After the demonstration of triclabendazole resistance on
the Dutch farm in the winter of 1998/99, resistance to the
drug was also observed in the same season on three other
farms in the vicinity of the first farm. In the autumn and win-
ter of 1999/2000, triclabendazole resistance was found on four
other farms, in 2000/01 on five farms and in 2001/02 on one
farm. Studies on the suspected cases in 2003 and 2004 are
ongoing. At the time of writing, the total number of Dutch
farms where resistance to triclabendazole has been found and
proven by a faecal egg count reduction test was 14. All the
farms are situated in the same area, and the greatest distance
between any two farms is less than 30 km. The farms are
located in the province of North Holland, in an area that is
below sea level, with ideal conditions for survival of a large
population of the mud snail Lymnaea truncatula even in ‘dry’
summers. Therefore, farmers need to treat their sheep with
fasciolicides several times per year. Following the demon-
stration of resistance to triclabendazole, farmers were advised
to use a fasciolicide with a different mode of action. In the
Netherlands, triclabendazole is the only fasciolicide registered
for use in sheep, but in proven cases of resistance, closantel
may be used under strict conditions and with the guidance of
a veterinarian.
In order to investigate whether there was a reversion
towards susceptibility to triclabendazole, in 2002 the authors
returned to the farm where resistance had first been demon-
strated in 1998/99 (Moll and others 2000). Since the demon-
stration of resistance on the farm, the farmer had treated his
sheep each year with closantel; generally, three treatments per
year were given, in the spring, autumn and winter. In autumn
2002, the farmer had sold all his sheep and bought new ani-
mals from a farm where liver fluke had never been found;
these liver fluke-free sheep were grazed on his pastures from
October 2002 onwards.
In December 2002, blood samples from five sheep were
taken to check for the presence of antibodies by means of a
F hepatica-specific serological test (Cornelissen and others
1992). All the sheep proved to be serologically positive, but
coprologically negative by the Dorsman (1956) technique.
This was not surprising, because the flukes were still in the
prepatent period. In February 2003, the same five sheep were
coprologically positive (range 2 to 50).
In March 2003, the efficacy of triclabendazole was tested
in 10 sheep (Table 1); the triclabendazole treatment had no
significant effect on the egg output after seven days.
Therefore, a second treatment, with closantel, was given; this
treatment proved to be effective. The efficacy of closantel
against triclabendazole-resistant F hepatica has been demon-
strated by Coles and others (2000) and Moll and others
(2000).
This study showed that three years of usage of a fascioli-
cide with a different mode of action to that of triclabendazole
did not result in reversion, that is, a return to susceptibility
to triclabendazole. This result is comparable to that reported
in the literature on the lack of reversion to susceptibility to
benzimidazole in resistant nematodes (Borgsteede and Duyn
1989). However, care must be taken when comparing rever-
sion in nematodes and trematodes. In nematodes, there may
susceptible infective larvae in refugia. With trematodes, which
undergo asexual multiplication in the intermediate host,
selection for resistance and the elimination of genes for sus-
ceptibility may develop more rapidly. This emphasises the
need to stop using a drug before a total failure of efficacy and
the impossibility of a return to susceptibility due to a lack of
‘susceptible’ genes. In such a scenario it may be possible to
reintroduce susceptible flukes from other areas, as has been
shown for Haemonchus contortus (van Wyk and others 2001).
The time between clearance of the farm of the original
sheep and restocking was far too short to have had any effect
on infection by resistant fluke in the bought-in sheep. It
would be worth investigating this strategy, while giving suf-
ficient time for the encysted herbage larvae and those within
snails to die off. However, wildlife, such as rabbits and hares,
might harbour and ensure the continued existence of the
resistant strain of F hepatica.
The present results, when combined with the recently
observed increase in fasciolosis in sheep and cattle in the UK
(Daniel and Mitchell 2002), indicate that there is an urgent
need for research and consultation on the correct use of avail-
able fasciolicides and alternative control strategies, such as
lowering the ground water level, good drainage, cleaning of
ditches, pasture management, alternative land use and avoid-
ing or fencing off pastures or parts of the pastures at risk.
Thought should also be given to the identification of biolog-
ical and other control measures for mud snails and pasture
larvae.
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Faecal egg count on
Sheep March 5* March 12 March 25†
1 15 15 10
2 30 15 0
3 380 380 0
4 730 430 0
5 740 1020 0
6 25 45 0
7 450 350 0
8 570 450 0
9 280 150 0
10 230 260 0
Mean 345 312 1
* Treatment with 10 mg/kg bodyweight triclabendazole
† One week after treatment with 10 mg/kg bodyweight closantel
on March 19
TABLE 1: Fluke egg counts in sheep before and after treatment
with triclabendazole and closantel in 2003
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